1. Home
  2. LIVE vs IFRX Comparison

LIVE vs IFRX Comparison

Compare LIVE & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Ventures Incorporated

LIVE

Live Ventures Incorporated

HOLD

Current Price

$14.76

Market Cap

30.3M

ML Signal

HOLD

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$1.05

Market Cap

71.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIVE
IFRX
Founded
1968
2007
Country
United States
Germany
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.3M
71.1M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
LIVE
IFRX
Price
$14.76
$1.05
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.50
AVG Volume (30 Days)
12.2K
909.6K
Earning Date
12-11-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.93
N/A
Revenue
$444,944,000.00
$73,729.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,075.42
P/E Ratio
$2.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.25
$0.71
52 Week High
$25.88
$2.77

Technical Indicators

Market Signals
Indicator
LIVE
IFRX
Relative Strength Index (RSI) 61.29 43.21
Support Level $9.05 $0.96
Resistance Level $17.35 $1.12
Average True Range (ATR) 1.56 0.09
MACD 0.77 -0.00
Stochastic Oscillator 68.26 34.70

Price Performance

Historical Comparison
LIVE
IFRX

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: